vancomycin 1000 mg powder for concentrate for solution for infusion
hikma farmacêutica (portugal) s.a. - vancomycin hydrochloride - powder for concentrate for solution for infusion - 1 gram(s) - glycopeptide antibacterials; vancomycin
vancomycin 500 mg powder for concentrate for solution for infusion
hikma farmacêutica (portugal) s.a. - vancomycin hydrochloride - powder for concentrate for solution for infusion - 500 milligram(s) - glycopeptide antibacterials; vancomycin
vancomycin farmaplus 1 grams pdr for soln for infusion
farmaplus as - vancomycin hydrochloride - pdr for soln for infusion - 1 grams
vancomycin farmaplus 500 milligram pdr/conc/soln for infus
farmaplus as - vancomycin hydrochloride - pdr/conc/soln for infus - 500 milligram
voluven 6 %w/v solution for infusion
fresenius kabi limited - poly(o-2-hydroxyethyl)starch, sodium chloride - solution for infusion - 6 %w/v - blood substitutes and plasma protein fractions
voluven 6% %w/v solution for infusion
fresenius kabi limited - poly(o-2-hydroxyethyl)starch, sodium chloride - solution for infusion - 6% %w/v - blood substitutes and plasma protein fractions
zoledronic acid fair med
fair-med healthcare gmbh - zoledronic acid monohydrate - concentrate for soln for inf - 4/5 mg/ml - tiludronic acid
vancomycin
generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 1000 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins.
vancomycin
generics (uk) limited - vancomycin hydrochloride - pdr/conc/soln for infus - 500 milligram - vancomycin - antibacterials for systemic use: glycopeptide antibacterials - it is used for severe infections, caused by gram-positive bacteria susceptible to vancomycin which cannot be treated with or failed to respond or are resistant to other antibiotics such as penicillins and cephalosporins
fluorouracil 50 mg/ml solution for inj/inf
generics (uk) limited - fluorouracil - solution for inj/inf - 50 mg/ml - pyrimidine analogues - pyrimidine analogues - it is indicated in the treatment of the following malignancies and disease settings: in the treatment of metastatic colorectal cancer; as adjuvant treatment in colon and rectal cancer; in the treatment of advanced gastric cancer; in the treatment of advanced pancreatic cancer; in the treatment of advanced oesophageal cancer; in the treatment of advanced or metastatic breast cancer; as adjuvant treatment in patients with operable primary invasive breast cancer; in the treatment of inoperable locally advanced squamous cell carcinoma of the head and neck in previously untreated patients; in the treatment of locally recurrent or metastatic squamous cell carcinoma of the head and neck